Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TGF-beta and cancer.

M Reiss1

  • 1Department of Medicine (Medical Oncology) and Yale Cancer Center, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, CT, USA.

Microbes and Infection
|December 28, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dehydropolymerisation of methylamine borane using a dinuclear 1,3-allenediyl bridged zirconocene complex.

Dalton transactions (Cambridge, England : 2003)·2018
Same author

[Not Available].

MMW Fortschritte der Medizin·2016
Same author

Neuroendocrine relationship and endocrinology in clinical psychiatry.

Recent progress in psychiatry·2014
Same author

Peritonsillar abscess: is there any evidence of lateralized distribution? An analysis of 294 patients.

Revue de laryngologie - otologie - rhinologie·2012
Same author

[Report from the Committee for Advanced Therapies (CAT). Pitfalls on the way from concept to medical treatment with advanced therapy medicinal products].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2011
Same author

Scaling of home range size: Body size, metabolic needs and ecology.

Trends in ecology & evolution·2011

Transforming growth factor-beta (TGF-beta) initially suppresses tumors but later promotes cancer progression. Cancer cells develop resistance to TGF-beta, impacting treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-beta (TGF-beta) exhibits complex roles in cancer development.
  • Emerging evidence suggests TGF-beta acts as a tumor suppressor in early carcinogenesis.
  • Later stages involve TGF-beta promoting malignant progression and tumor microenvironment changes.

Purpose of the Study:

  • To elucidate the dual role of TGF-beta in cancer.
  • To understand the mechanisms of TGF-beta resistance in tumor cells.
  • To explore the implications of TGF-beta's changing role for cancer therapy.

Main Methods:

  • Review of experimental evidence on TGF-beta signaling in carcinogenesis.
  • Analysis of genetic alterations in TGF-beta pathway components.

Related Experiment Videos

  • Examination of phenotypic switch from TGF-beta sensitivity to resistance.

    • Main Results:

    • TGF-beta functions as a tumor suppressor early in cancer, potentially aided by chemopreventive agents.
    • Tumor cells acquire resistance to TGF-beta during progression, often due to mutations in signaling intermediates like TGF-beta receptors and Smads.
    • The precise stage of resistance development varies across different cancer types.

    Conclusions:

    • TGF-beta's role shifts from tumor suppression to tumor promotion during carcinogenesis.
    • Acquired resistance to TGF-beta is a critical event in malignant progression.
    • Understanding this phenotypic switch is crucial for developing effective cancer prevention and treatment strategies.